🇺🇸 FDA
Drug

pimecrolimus

Brand: ELIDEL

approved

Quick answer

pimecrolimus (ELIDEL), is a pharmaceutical active ingredient, with approved status in the US.

Key facts

INN
pimecrolimus
Brand
ELIDEL
Route
TOPICAL
Formulation
CREAM

Related patents

patent

US 7589100

Non-hygroscopic and powdery amorphous pimecrolimus

Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 7279571

Methods of preparing pimecrolimus

Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is pimecrolimus?

pimecrolimus (ELIDEL), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for pimecrolimus?

ELIDEL is a marketed brand name for pimecrolimus. Check FDA Drugs@FDA for the current US label holder.